Fortress Biotech Inc (FBIO)

11:01 AM

Fortress Biotech price target lowered to $4 from $5 at Alliance Global Partners - TipRanks

11:01 AM

07:44 AM

Fortress Biotech price target raised to $26 from $24 at H.C. Wainwright - TipRanks

07:44 AM

07:41 AM

Fortress Biotech (FRA:CNB1) Total Inventories : €9.00 Mil (As of Jun. 2024) - GuruFocus.com

07:41 AM

Nov 17, 2024

Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

Fortress Biotech: Q3 Earnings Snapshot - mySA

Nov 15, 2024

Nov 15, 2024

Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Fortress Biotech’s Q3 2024 Earnings and FDA Milestone - TipRanks

Nov 14, 2024

Nov 14, 2024

Fortress Biotech Q3 2024 Earnings: EPS Loss of $0.76 Beats Estimate, Revenue of $14.63M Misses Expectations - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Avenue Therapeutics Reports $3.1M Q3 Loss, Advances Key Clinical Trials Pipeline | ATXI Stock News - StockTitan

Nov 14, 2024

Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024

Nov 12, 2024

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss | FBIO Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Journey Medical's Mixed Q3: FDA Win for Rosacea Drug Despite Revenue Dip | FBIO Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024

Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024

Nov 12, 2024

Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Where are the Opportunities in (FBIOP) - Stock Traders Daily

Nov 12, 2024

Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India

Nov 07, 2024

Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK

Nov 07, 2024

Nov 01, 2024

How To Trade (FBIOP) - Stock Traders Daily

Nov 01, 2024

Oct 31, 2024

Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m - Yahoo Finance

Oct 31, 2024

Oct 30, 2024

Biotech Stocks Facing FDA Decision In November 2024 - RTTNews

Oct 30, 2024

Oct 29, 2024

Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 36% But Its Business Still Trails The Industry - Simply Wall St

Oct 29, 2024

Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortres - GuruFocus.com

Oct 25, 2024

Oct 25, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewswire

Oct 25, 2024

Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024

Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - The Manila Times

Oct 24, 2024

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - The Manila Times

Oct 09, 2024

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024

Oct 07, 2024

Analysts review Fortress Biotech Inc’s rating - Knox Daily

Oct 07, 2024

Oct 07, 2024

Was there any good news for Fortress Biotech Inc (FBIO) stock in the last session? - US Post News

Oct 07, 2024

Oct 03, 2024

PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD acquire 763,359 shares of Fortress Biotech Inc [FBIO] - Knox Daily

Oct 03, 2024

Oct 03, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire

Oct 03, 2024

Oct 02, 2024

Fortress Biotech Inc (FBIO) expanding its growth trajectory ahead - SETE News

Oct 02, 2024

Oct 01, 2024

Nantahala Capital Management LLC Sells 125,000 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Oct 01, 2024

Oct 01, 2024

PVG Asset Management Corp Invests $266,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Oct 01, 2024

Sep 30, 2024

Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily

Sep 30, 2024

Sep 30, 2024

Fortress Biotech Inc (FBIO)’s results reveal risk - US Post News

Sep 30, 2024